BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35500223)

  • 1. Metformin for treatment of cytopenias in children and young adults with Fanconi anemia.
    Pollard JA; Furutani E; Liu S; Esrick E; Cohen LE; Bledsoe J; Liu CW; Lu K; de Haro MJR; Surrallés J; Malsch M; Kuniholm A; Galvin A; Armant M; Kim AS; Ballotti K; Moreau L; Zhou Y; Babushok D; Boulad F; Carroll C; Hartung H; Hont A; Nakano T; Olson T; Sze SG; Thompson AA; Wlodarski MW; Gu X; Libermann TA; D'Andrea A; Grompe M; Weller E; Shimamura A
    Blood Adv; 2022 Jun; 6(12):3803-3811. PubMed ID: 35500223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.
    Zhang QS; Tang W; Deater M; Phan N; Marcogliese AN; Li H; Al-Dhalimy M; Major A; Olson S; Monnat RJ; Grompe M
    Blood; 2016 Dec; 128(24):2774-2784. PubMed ID: 27756748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the bone marrow failure in Fanconi anemia patients with danazol.
    Scheckenbach K; Morgan M; Filger-Brillinger J; Sandmann M; Strimling B; Scheurlen W; Schindler D; Göbel U; Hanenberg H
    Blood Cells Mol Dis; 2012 Feb; 48(2):128-31. PubMed ID: 22178060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.
    Paustian L; Chao MM; Hanenberg H; Schindler D; Neitzel H; Kratz CP; Ebell W
    Pediatr Hematol Oncol; 2016 Feb; 33(1):5-12. PubMed ID: 26900943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.
    Rackoff WR; Orazi A; Robinson CA; Cooper RJ; Alter BP; Freedman MH; Harris RE; Williams DA
    Blood; 1996 Sep; 88(5):1588-93. PubMed ID: 8781414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
    Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
    Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia.
    Feben C; Kromberg J; Wainwright R; Stones D; Poole J; Haw T; Krause A
    Blood Cells Mol Dis; 2015 Mar; 54(3):270-4. PubMed ID: 25477267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-dependent metabolic effects of metformin in healthy and Fanconi anemia lymphoblast cells.
    Ravera S; Cossu V; Tappino B; Nicchia E; Dufour C; Cavani S; Sciutto A; Bolognesi C; Columbaro M; Degan P; Cappelli E
    J Cell Physiol; 2018 Feb; 233(2):1736-1751. PubMed ID: 28681917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term combination therapy with metformin and oxymetholone in a Fanconi anemia mouse model.
    Dorrell C; Peters AM; Zhang Q; Balaji N; Baradar K; Mochizuki-Kashio M; Major A; Finegold M; Liu CW; Lu K; Grompe M
    Pediatr Blood Cancer; 2024 May; ():e31030. PubMed ID: 38733122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.
    Chang YH; Shaw CF; Wu KH; Hsieh KH; Su YN; Lu PJ
    Hemoglobin; 2009; 33(5):346-51. PubMed ID: 19814681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe telomere shortening in Fanconi anemia complementation group L.
    Shah A; George M; Dhangar S; Rajendran A; Mohan S; Vundinti BR
    Mol Biol Rep; 2021 Jan; 48(1):585-593. PubMed ID: 33394227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
    Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
    Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.
    Nicoletti E; Rao G; Bueren JA; Río P; Navarro S; Surrallés J; Choi G; Schwartz JD
    Ann Hematol; 2020 May; 99(5):913-924. PubMed ID: 32065290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
    Lakhi NA; Mizejewski GJ
    Fetal Pediatr Pathol; 2017 Feb; 36(1):49-61. PubMed ID: 27690720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of Fanconi anemia: A developmental and therapeutic perspective on a multifaceted disease.
    Guitton-Sert L; Gao Y; Masson JY
    Semin Cell Dev Biol; 2021 May; 113():113-131. PubMed ID: 33558144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
    Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fanconi anemia is characterized by delayed repair kinetics of DNA double-strand breaks.
    Leskovac A; Vujic D; Guc-Scekic M; Petrovic S; Joksic I; Slijepcevic P; Joksic G
    Tohoku J Exp Med; 2010 May; 221(1):69-76. PubMed ID: 20453460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.